Supernus Pharmaceuticals, Inc.
HealthcareNASDAQ:SUPN · NASDAQ Global Market
-$1.14 today
Vol 0.82M · Avg 0.63M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+38.65%
Period High
$57.00
Period Low
$31.16
Latest
$44.41
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Lantheus Holdings, Inc.
NASDAQ:LNTH
$6.80B
Centessa Pharmaceuticals plc
NASDAQ:CNTA
$6.15B
CG Oncology, Inc. Common stock
NASDAQ:CGON
$5.25B
Amneal Pharmaceuticals, Inc.
NASDAQ:AMRX
$5.17B
Indivior Pharmaceuticals Inc
NASDAQ:INDV
$4.80B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.11B
GRAIL, Inc.
NASDAQ:GRAL
$2.57B
HUTCHMED (China) Limited
NASDAQ:HCM
$1.91B
Bausch Health Companies Inc.
NYSE:BHC
$1.89B
Perrigo Company plc
NYSE:PRGO
$1.52B
What is the latest SUPN filing?
The latest filing shown is 8-K dated May 20, 2026.
How many recent filings does SUPN have?
Intrinsic Alpha currently shows 20 recent filings for SUPN.
Explore More
Continue the stock analysis
Jump to another research area for this company.